BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16652378)

  • 1. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
    Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
    Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
    Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
    Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
    Suizu F; Ryo A; Wulf G; Lim J; Lu KP
    Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
    Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
    Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
    Zhou XZ; Kops O; Werner A; Lu PJ; Shen M; Stoller G; Küllertz G; Stark M; Fischer G; Lu KP
    Mol Cell; 2000 Oct; 6(4):873-83. PubMed ID: 11090625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
    Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
    Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1.
    Lippens G; Landrieu I; Smet C
    FEBS J; 2007 Oct; 274(20):5211-22. PubMed ID: 17892493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
    Kim G; Kim JY; Choi HS
    Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
    Finn G; Lu KP
    Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells.
    Khanal P; Kim G; Yun HJ; Cho HG; Choi HS
    Mol Carcinog; 2013 Oct; 52(10):813-23. PubMed ID: 22549912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
    Marsolier J; Weitzman JB
    Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55.
    van der Horst A; Khanna KK
    Cancer Res; 2009 Aug; 69(16):6651-9. PubMed ID: 19638580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolyl isomerase Pin1 in breast development and cancer.
    Wulf G; Ryo A; Liou YC; Lu KP
    Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.
    Wulf G; Garg P; Liou YC; Iglehart D; Lu KP
    EMBO J; 2004 Aug; 23(16):3397-407. PubMed ID: 15257284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.
    Lee TH; Pastorino L; Lu KP
    Expert Rev Mol Med; 2011 Jun; 13():e21. PubMed ID: 21682951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.